{"name":"Roche Venture Fund","permalink":"roche-venture-fund","crunchbase_url":"http://www.crunchbase.com/financial-organization/roche-venture-fund","homepage_url":"http://www.venturefund.roche.com/","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"","description":"","email_address":"roche.venturefund@roche.com","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Fri Apr 17 12:11:12 UTC 2009","updated_at":"Mon Jun 01 21:35:54 UTC 2009","overview":"<p>The Roche Venture Fund is the name given to the corporate venture fund of the healthcare company Roche. Roche has allocated CHF 500 million to invest in and develop commercially successful innovative life science companies. </p>\n\n<p>Roche has been investing in early stage companies as part of collaborations since the early-1990s and independent of collaborations since 2002. All equity investments made by Roche in biotech and diagnostics companies (including collaboration investments) are negotiated and managed by the Roche Venture Fund. In the past 20 years, the Roche Venture Fund has invested in over 60 companies globally. Currently, Roche Venture Fund has a portfolio of around 30 companies located in 10 countries across Europe, North America and the Pacific Region. The fund is an evergreen fund with CHF 500 million available of which approximately 40% is currently invested.</p>\n\n<p>The Roche Venture Fund is a committed long-term stable investor with sufficient money reserved in their fund for follow-on financing rounds. As part of a multinational healthcare company, the Roche Venture Fund has access to considerable expertise both internally and externally. We co-invest with leading venture funds, including other corporate venture funds, on a regular basis.</p>","image":{"available_sizes":[[[150,21],"assets/images/resized/0004/6088/46088v1-max-150x150.jpg"],[[156,22],"assets/images/resized/0004/6088/46088v1-max-250x250.jpg"],[[156,22],"assets/images/resized/0004/6088/46088v1-max-450x450.jpg"]],"attribution":null},"offices":[{"description":"","address1":"Grenzacherstrasse 124","address2":"","zip_code":"CH-4070","city":"Basel","state_code":null,"country_code":"CHE","latitude":47.5586243,"longitude":7.6060181}],"relationships":[{"is_past":false,"title":"Head of Roche Venture Fund","person":{"first_name":"Carole","last_name":"Nuechterlein","permalink":"carole-nuechterlein","image":null}},{"is_past":false,"title":"Investment Director","person":{"first_name":"Simon","last_name":"Meier","permalink":"simon-meier","image":null}}],"investments":[{"funding_round":{"round_code":"a","source_url":"http://www.aliosbiopharma.com/index.php/alios/press_releases/58/","source_description":"Alios BioPharma, Inc. Completes First Closing of Series A Financing with Commitment of $24 MM from 3","raised_amount":24000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":2,"funded_day":12,"company":{"name":"Alios BioPharma","permalink":"alios-biopharma","image":{"available_sizes":[[[114,71],"assets/images/resized/0004/1670/41670v1-max-150x150.png"],[[114,71],"assets/images/resized/0004/1670/41670v1-max-250x250.png"],[[114,71],"assets/images/resized/0004/1670/41670v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"","source_description":"Capital Funding Report","raised_amount":22000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":6,"funded_day":2,"company":{"name":"Inimex Pharmaceuticals","permalink":"inimex-pharmaceuticals","image":{"available_sizes":[[[125,46],"assets/images/resized/0004/6632/46632v1-max-150x150.jpg"],[[125,46],"assets/images/resized/0004/6632/46632v1-max-250x250.jpg"],[[125,46],"assets/images/resized/0004/6632/46632v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.fiercebiotech.com/story/alios-raises-another-8m/2009-06-11?utm_medium=rss&utm_source=rss&cmp-id=OTC-RSS-FB0","source_description":"Alios raises another $8M","raised_amount":8000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":6,"funded_day":11,"company":{"name":"Alios BioPharma","permalink":"alios-biopharma","image":{"available_sizes":[[[114,71],"assets/images/resized/0004/1670/41670v1-max-150x150.png"],[[114,71],"assets/images/resized/0004/1670/41670v1-max-250x250.png"],[[114,71],"assets/images/resized/0004/1670/41670v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.zibb.com/article/5328061/Aileron+Therapeutics+Closes+Series+D+Financing?expired=4556347","source_description":"Aileron Therapeutics Closes Series D Financing","raised_amount":40000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":6,"funded_day":11,"company":{"name":"Aileron Therapeutic","permalink":"aileron-therapeutics","image":{"available_sizes":[[[150,87],"assets/images/resized/0004/8789/48789v1-max-150x150.png"],[[153,89],"assets/images/resized/0004/8789/48789v1-max-250x250.png"],[[153,89],"assets/images/resized/0004/8789/48789v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://onbiovc.com/opsona-therapeutics-ltd-series-b-46m/","source_description":"Opsona Therapeutics, Ltd.: Series B $4.6M","raised_amount":4600000,"raised_currency_code":"USD","funded_year":2009,"funded_month":6,"funded_day":16,"company":{"name":"Opsona","permalink":"opsona","image":{"available_sizes":[[[150,51],"assets/images/resized/0004/8845/48845v1-max-150x150.png"],[[219,75],"assets/images/resized/0004/8845/48845v1-max-250x250.png"],[[219,75],"assets/images/resized/0004/8845/48845v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.fiercebiotech.com/press-releases/intradigm-corporation-closes-final-tranche-21-4-million-series-b-financing-philip-haw","source_description":"Intradigm Corporation Closes Final Tranche of $21.4 Million Series B Financing; Philip Haworth, Ph.D. Appointed Chief Executive","raised_amount":21400000,"raised_currency_code":"USD","funded_year":2009,"funded_month":1,"funded_day":7,"company":{"name":"Intradigm Corporation","permalink":"intradigm-corporation","image":{"available_sizes":[[[150,34],"assets/images/resized/0005/0666/50666v1-max-150x150.png"],[[250,56],"assets/images/resized/0005/0666/50666v1-max-250x250.png"],[[316,72],"assets/images/resized/0005/0666/50666v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/cellerix-sl-series-c-377m/","source_description":"Cellerix, SL: Series C $37.7M","raised_amount":37700000,"raised_currency_code":"USD","funded_year":2010,"funded_month":1,"funded_day":28,"company":{"name":"Cellerix","permalink":"cellerix","image":{"available_sizes":[[[150,69],"assets/images/resized/0006/5847/65847v1-max-150x150.png"],[[195,90],"assets/images/resized/0006/5847/65847v1-max-250x250.png"],[[195,90],"assets/images/resized/0006/5847/65847v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.cellerix.com/Press-Room/Last-News/Cellerix-closes-27-2m-financing-round-to-bring-product-Cx401-to-market","source_description":"Cellerix closes â‚¬27,2m financing round to bring product Cx401 to market","raised_amount":27200000,"raised_currency_code":"EUR","funded_year":2007,"funded_month":9,"funded_day":20,"company":{"name":"Cellerix","permalink":"cellerix","image":{"available_sizes":[[[150,69],"assets/images/resized/0006/5847/65847v1-max-150x150.png"],[[195,90],"assets/images/resized/0006/5847/65847v1-max-250x250.png"],[[195,90],"assets/images/resized/0006/5847/65847v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"e","source_url":"http://onbiovc.com/nereus-pharmaceuticals-inc-series-e-20m/","source_description":"Nereus Pharmaceuticals, Inc.: Series E $20M","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":25,"company":{"name":"Nereus Pharmaceuticals","permalink":"nereus-pharmaceuticals","image":null}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2010/09/cytomx-therapeutics-completes-30m.html","source_description":"CytomX Therapeutics Completes $30M Series B Financing","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":9,"funded_day":23,"company":{"name":"CytomX Therapeutics","permalink":"cytomx-therapeutics","image":{"available_sizes":[[[150,51],"assets/images/resized/0010/3203/103203v1-max-150x150.jpg"],[[250,85],"assets/images/resized/0010/3203/103203v1-max-250x250.jpg"],[[293,100],"assets/images/resized/0010/3203/103203v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=32&aid=DJFVW00020100928e69t001gw&r=Rss&s=DJFVW","source_description":"Horizon Discovery Raises $9.8M For Genetic Modeling  ","raised_amount":9800000,"raised_currency_code":"USD","funded_year":2010,"funded_month":9,"funded_day":28,"company":{"name":"Horizon Discovery","permalink":"horizon-discovery","image":{"available_sizes":[[[150,56],"assets/images/resized/0004/7571/47571v3-max-150x150.png"],[[250,94],"assets/images/resized/0004/7571/47571v3-max-250x250.png"],[[450,169],"assets/images/resized/0004/7571/47571v3-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://pharmalive.com/News/Index.cfm?articleid=761182","source_description":"Conatus Pharmaceuticals Completes $20 Million Series B Private Placement Financing","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":2,"funded_day":11,"company":{"name":"Conatus Pharmaceuticals","permalink":"conatus-pharmaceuticals","image":{"available_sizes":[[[150,39],"assets/images/resized/0012/1771/121771v1-max-150x150.jpg"],[[197,52],"assets/images/resized/0012/1771/121771v1-max-250x250.jpg"],[[197,52],"assets/images/resized/0012/1771/121771v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.ambitbio.com/news/press_061011.htm","source_description":"AMBIT BIOSCIENCES COMPLETES $30 MILLION SERIES D-2 FINANCING","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":6,"funded_day":10,"company":{"name":"Ambit Biosciences","permalink":"ambit-biosciences","image":{"available_sizes":[[[95,108],"assets/images/resized/0013/8681/138681v1-max-150x150.png"],[[95,108],"assets/images/resized/0013/8681/138681v1-max-250x250.png"],[[95,108],"assets/images/resized/0013/8681/138681v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.biospace.com/News/cambridge-spin-out-mission-therapeutics-raises-10/231199","source_description":"MissionTherapeutics Ltd Raises $10 Million, Eyes Rapid Growth","raised_amount":10000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":8,"funded_day":25,"company":{"name":"MISSION Therapeutics","permalink":"mission-therapeutics","image":{"available_sizes":[[[150,65],"assets/images/resized/0015/1183/151183v1-max-150x150.jpg"],[[250,108],"assets/images/resized/0015/1183/151183v1-max-250x250.jpg"],[[255,111],"assets/images/resized/0015/1183/151183v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.curetis.com/fileadmin/curetis/media/struktur/News_Media/Press_Releases/20111026_Curetis_Financing_ENGL_V1.0R_.pdf","source_description":"Series A financing round expended to 34.1 euro","raised_amount":9600000,"raised_currency_code":"EUR","funded_year":2011,"funded_month":10,"funded_day":26,"company":{"name":"Curetis","permalink":"curetis","image":{"available_sizes":[[[150,48],"assets/images/resized/0006/8508/68508v1-max-150x150.jpg"],[[200,64],"assets/images/resized/0006/8508/68508v1-max-250x250.jpg"],[[200,64],"assets/images/resized/0006/8508/68508v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/horizon-discovery-ltd-series-c-186m/","source_description":"Horizon Discovery, Ltd.: Series C $18.6M","raised_amount":18600000,"raised_currency_code":"USD","funded_year":2012,"funded_month":1,"funded_day":16,"company":{"name":"Horizon Discovery","permalink":"horizon-discovery","image":{"available_sizes":[[[150,56],"assets/images/resized/0004/7571/47571v3-max-150x150.png"],[[250,94],"assets/images/resized/0004/7571/47571v3-max-250x250.png"],[[450,169],"assets/images/resized/0004/7571/47571v3-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2012/09/foundation-medicine-closes-42-5m-series-funding.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Foundation Medicine Closes $42.5M Series B Funding","raised_amount":42500000,"raised_currency_code":"USD","funded_year":2012,"funded_month":9,"funded_day":20,"company":{"name":"Foundation Medicine","permalink":"foundation-medicine","image":{"available_sizes":[[[150,84],"assets/images/resized/0013/4432/134432v1-max-150x150.png"],[[214,120],"assets/images/resized/0013/4432/134432v1-max-250x250.png"],[[214,120],"assets/images/resized/0013/4432/134432v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://finance.yahoo.com/news/ambit-biosciences-completes-50-million-130000590.html","source_description":"Ambit Biosciences Completes $50 Million Financing to Advance Lead Drug Candidate in Acute Myeloid Leukemia","raised_amount":50000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":11,"funded_day":6,"company":{"name":"Ambit Biosciences","permalink":"ambit-biosciences","image":{"available_sizes":[[[95,108],"assets/images/resized/0013/8681/138681v1-max-150x150.png"],[[95,108],"assets/images/resized/0013/8681/138681v1-max-250x250.png"],[[95,108],"assets/images/resized/0013/8681/138681v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2012/11/epic-sciences-completes-13m-series-equity-financing.html","source_description":"Epic Sciences Completes $13M Series B Equity Financing","raised_amount":13000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":11,"funded_day":13,"company":{"name":"Epic Sciences","permalink":"epic-sciences","image":{"available_sizes":[[[150,31],"assets/images/resized/0022/0799/220799v1-max-150x150.jpg"],[[250,52],"assets/images/resized/0022/0799/220799v1-max-250x250.jpg"],[[335,70],"assets/images/resized/0022/0799/220799v1-max-450x450.jpg"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}